Insider Transactions in Q1 2025 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2025
|
Kevin Koch President and CEO |
SELL
Open market or private sale
|
Direct |
900
-5.85%
|
$27,900
$31.13 P/Share
|
|
Feb 06
2025
|
Kevin Koch President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+5.53%
|
$11,700
$13.11 P/Share
|
|
Feb 06
2025
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,200
-7.47%
|
$36,000
$30.13 P/Share
|
|
Feb 06
2025
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+6.95%
|
$0
$0.18 P/Share
|
|
Feb 05
2025
|
Behrad Derakhshan Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-37.26%
|
$300,000
$30.03 P/Share
|
|
Feb 05
2025
|
Behrad Derakhshan Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.15%
|
$10,000
$1.93 P/Share
|
|
Feb 05
2025
|
Kevin Koch President and CEO |
SELL
Open market or private sale
|
Direct |
8,636
-37.36%
|
$259,080
$30.03 P/Share
|
|
Feb 05
2025
|
Kevin Koch President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+27.2%
|
$0
$0.18 P/Share
|
|
Feb 05
2025
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,015
-35.03%
|
$240,450
$30.02 P/Share
|
|
Feb 05
2025
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,015
+25.94%
|
$0
$0.18 P/Share
|
|
Jan 28
2025
|
Joanne M. Donovan CMO |
SELL
Open market or private sale
|
Direct |
25,000
-60.45%
|
$675,000
$27.63 P/Share
|
|
Jan 28
2025
|
Joanne M. Donovan CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+37.67%
|
$175,000
$7.08 P/Share
|